Pi-Cardia Ltd.

Company Summary

Pi-Cardia developed the Leaflex™ Catheter System - a novel non-implant based technology for treating patients with aortic valve stenosis The Leaflex™ is a low-profile trans-femoral catheter which delivers mechanical energy in order to create substantial fractures in valve calcification

Transaction Overview

$10 Million Series C round completed, led by an undisclosed major strategic

‍

Significance of the Transaction

Expand the treatment options in the rapidly growing multi-billion dollar market currently dominated by surgical or trans-catheter aortic valve replacement

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Private Placement

Pi-Cardia Ltd.

Has completed series C financing led by undisclosed major strategic

The undersigned acted as exclusive advisor to Pi-cardia ltd.